EphA2 could activate Wnt/beta‐catenin and Hippo signalling pathways, which in turn induced EMT and downstream signalling cascade, thus mediating tumour invasiveness and resistance to cancer therapeutics in gastric cancer.8, 11. The gene discussed is EPHA2; the disease is gastric cancer.